Trademark Attorney / Law Firm
James A. Gale, Jeffrey D. Feldman, Janet T. Munn, Stephanie C. Alvarez and Rafael A. Perez-Pineiro – Trademark Portfolio
James A. Gale, Jeffrey D. Feldman, Janet T. Munn, Stephanie C. Alvarez and Rafael A. Perez-Pineiro specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 1 total filing concentrated in this category. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
James A. Gale, Jeffrey D. Feldman, Janet T. Munn, Stephanie C. Alvarez and Rafael A. Perez-Pineiro's trademark practice covers 1 Nice Classification class, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademark applications has James A. Gale, Jeffrey D. Feldman, Janet T. Munn, Stephanie C. Alvarez and Rafael A. Perez-Pineiro filed?
James A. Gale, Jeffrey D. Feldman, Janet T. Munn, Stephanie C. Alvarez and Rafael A. Perez-Pineiro has filed 1 trademark application with the United States Patent and Trademark Office (USPTO).
What trademark classes does James A. Gale, Jeffrey D. Feldman, Janet T. Munn, Stephanie C. Alvarez and Rafael A. Perez-Pineiro specialize in?
James A. Gale, Jeffrey D. Feldman, Janet T. Munn, Stephanie C. Alvarez and Rafael A. Perez-Pineiro has filed trademarks across 1 Nice Classification class. The most common practice areas include Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is James A. Gale, Jeffrey D. Feldman, Janet T. Munn, Stephanie C. Alvarez and Rafael A. Perez-Pineiro's trademark registration success rate?
James A. Gale, Jeffrey D. Feldman, Janet T. Munn, Stephanie C. Alvarez and Rafael A. Perez-Pineiro has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.